You are here

  • Home
  • Archive
  • Volume 69, Issue 8
  • Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Article metrics

Article menu
Download PDFPDF
PostScript
Letter
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 202017011682456
Jun 2020898883205
Jul 2020714688185
Aug 2020401372143
Sep 2020370316220
Oct 2020212215113
Nov 202020819884
Dec 202020218784
Jan 202132230685
Feb 202138236585
Mar 202120819976
Apr 202117115596
May 202117415372
Jun 202116215355
Jul 202120019373
Aug 202119318574
Sep 202122021081
Oct 202161661299
Nov 202117916875
Dec 202118718146
Jan 202219517545
Feb 202222321529
Mar 202217516234
Apr 202214213135
May 202215815046
Jun 202211611257
Jul 202211010634
Aug 202211810827
Sep 202215015245
Oct 202213812436
Nov 202211210123
Dec 202276729
Jan 2023998521
Feb 2023908312
Mar 20231069226
Apr 2023163161
May 202334363
Jun 202311361
Jul 20236051
Aug 202316096
Sep 202311093
Oct 202320155
Nov 202310354
Dec 202314722
Jan 202412649
Feb 202420114
Mar 202411444
Total1156993612929